perioperative management of glp 1 agonists How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations

Discard and start a new vial

This is the first step in the transport of fatty acids into the mitochondria

Here's why that combination is interesting: rapamycin inhibits mTOR, the cellular growth pathway that, when chronically overactivated, drives cellular senescence in follicle stem cell niches

When used together, the compounds appear to engage complementary biological pathways, providing a more comprehensive approach to structural and functional support at the tissue level

GLP-1R agonism not only helps with weight management but also appears to provide neuroprotective effects, including reducing neuroinflammation and enhancing brain health